2011 High-Throughput Chemistry and Chemical Biology Gordon Research Seminar
2011 High-Throughput Chemistry and Chemical Biology Gordon Research Seminar
批准号:
8189545
负责人:
William Charles Krause Pomerantz
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-05-31
关键词:
AddressAreaBiochemistryBiological ProcessBiologyBusinessesChemicalsChemistryCollaborationsCoupledDevelopmentDisciplineEmerging TechnologiesEnvironmentEvaluationFeedbackFertilizationFosteringGoalsGovernmentInfusion proceduresLaboratoriesLeadLocationMentorshipMethodsMolecular BankMolecular BiologyParticipantPharmaceutical ChemistryPositioning AttributePostdoctoral FellowProtein EngineeringResearchResearch PersonnelScientistScreening procedureSenior ScientistShapesSiteSocial InteractionStudentsSynthesis ChemistryTalentsTechnologyTimeUniversitiesVeteransWritingbasecareercareer developmentcollegedesigndrug discoveryfrontiergraduate studentinnovationmultidisciplinarypeerpostersprofessorprogramssocialsuccesssymposium
中文摘要
描述(由申请人提供):高通量化学和化学生物学的戈登研究研讨会(GRS)是一个为期两天的会议,旨在突出新筛选技术,高质量分子库开发和跨学科化学生物学方法的高通量方法的最新进展,以统一合成化学和分子生物学领域。GRS的目标是促进早期职业科学家的研究,并培养药物发现领域的下一代领导者。成功的科学计划、有效的专业发展以及早期职业科学家和高级研究人员之间的协同互动将通过三个具体目标来实现:(1)开发尖端科学计划,展示高通量化学和化学领域的最新进展生物学。(2)为早期职业科学家创造导师/职业机会(3)促进GRS和GRC参与者之间增加和持续的科学对话,以促进药物发现领域的新创新思想。 GRS的特点是由研究生和博士后研究人员谁是在各自领域的新兴领导者介绍。GRS的出席人数上限为50人。GRS的亲密大小和位置为年轻科学家提供了一个环境,让他们向直接的同行展示他们的研究,促进了充满活力的科学话语,并鼓励在GRS和戈登研究会议(GRC)期间立即参与。为期两天的科学计划将包括三个科学会议和两个海报会议。十个科学讲座将提供足够的时间进行讨论。所有的演讲将由研究生或博士后研究人员与吉姆教授威尔斯,(加州大学旧金山分校),在蛋白质工程,生物化学和药物发现国际公认的领导者的主题演讲除外。为了促进与高级研究人员的互动,每次会议将由一名高级研究科学家和一名研究生或博士后研究员共同主持。最后,一个正式的专业发展/职业小组将结束会议。该小组将由学者、工业科学家和一名博士后研究员组成。
公共卫生相关性:药物发现受益于来自与该领域相关的许多学科的新思想的持续注入,特别是包括高通量化学和化学生物学学科。此外,该领域的持续进步和持续创新需要不断涌入新科学家,贡献新的想法,并融入药物发现领域。戈登研究研讨会(GRS)提供了这样一个论坛,通过引入研究生和博士后研究人员来展示各自领域的最新成果,并通过正式的导师/职业发展组件鼓励他们的科学发展。
英文摘要
DESCRIPTION (provided by applicant): The Gordon Research Seminar (GRS) for High-Throughput Chemistry and Chemical Biology is a two-day conference designed to highlight the state-of-the-art advances in high-throughput methods for new screening technologies, high-quality molecular library development and cross-disciplinary chemical biology methods to unite the fields of synthetic chemistry and molecular biology. The goal of the GRS is to promote the research of early career scientists and develop the next leaders in the field of drug discovery. A successful scientific program, effective professional development, and synergistic interactions between early career scientists and senior researchers will be achieved through three specific aims: (1) Development of a cutting-edge scientific program presenting recent advances from the fields of high-throughput chemistry and chemical biology. (2) Creation of mentorship/career opportunities for early career scientist (3) Promotion of increased and sustained scientific discourse between GRS and GRC participants for fostering new innovative ideas in the area of drug discovery. The GRS features presentations by graduate students and postdoctoral researchers who are emerging leaders in their respective fields. Attendance of the GRS is capped at 50 participants. The intimate size and location of a GRS provides an environment for junior scientists to present their research to their immediate peers facilitates spirited scientific discourse and encourages participation throughout the duration of both the GRS and the Gordon Research Conference (GRC) to immediately follow. The two-day scientific program will include three scientific sessions and two poster sessions. Ten scientific talks will be presented with adequate time for discussion. All presentations will be by graduate students or postdoctoral researchers with the exception of a Keynote address by Professor Jim Wells, (UCSF), an internationally recognized leader in protein engineering, biochemistry, and drug discovery. To foster interactions with senior researchers, each session will be co-chaired by a senior research scientist and either a graduate student or postdoctoral researcher. Finally, a formal professional development/ career panel will conclude the conference. The panel will be composed of academics, industrial scientists and a postdoctoral research fellow.
PUBLIC HEALTH RELEVANCE: Drug discovery benefits from a continual infusion of new ideas from many disciplines associated with this field specifically including the disciplines of high- throughput chemistry and chemical biology. Further, continued progress and sustained innovation for the field requires a continuous influx of new scientists contributing new ideas and becoming integrated into the field of drug discovery. The Gordon Research Seminar (GRS) provides such a forum, by bringing in graduate student and postdoctoral researchers to present the latest results in their respective fields, and encourages their scientific development through formal mentorship/career development components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10796381
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10375536
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10165958
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10554380
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Small Molecule Transcriptional Activator-Coactivator Interactions
-
批准号:8013603
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Small Molecule Transcriptional Activator-Coactivator Interactions
-
批准号:7806222
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:William Charles Krause Pomerantz
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: